Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prost... (a href'mailto:mwagner@debiopharm.com' ta...)

(Date:11/19/2009)...st people would like to be able to charge their ce...nd not too often. A recent discovery made by UC Sa...sed supercapacitors that could do just this. , ...Letters , Prabhakar Bandaru, a professor in the UC...ing, along with graduate student Mark Hoefer, have...

(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...

(Date:11/19/2009)... , ,, BETHESDA, Md., Nov. 19 /PRNewswir...X ), an innovator in biotechnology for diabetes th...consulting services to food, supplement, biotechno... it closed the previously reported $6.3 million re...rs of 2,760,870 shares of its common stock and war...

(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha... of Tuesday,s Annual Meeting of Shareholders. ,...ated (Nasdaq: SPEX ) elected the following member...

Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8 Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2 Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3 Spherix Announces Results of Annual Shareholders Meeting 2 Spherix Announces Results of Annual Shareholders Meeting 3 Spherix Announces Results of Annual Shareholders Meeting 4

[0] Nanotube defects equal better energy and storage systems [0] Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights [0] Spherix Announces the Closing of $6.3 Million Registered Direct Offering [0] Spherix Announces Results of Annual Shareholders Meeting

...BioTechnology, Inc.,announced today that it has be...wal Small Business Innovation Research (SBIR) gran...ple Sclerosis", from the National,Institute of Neu...onal,Institutes of Health (NIH). Receipt of the en...t of certain research milestones., George (Joe) C...

...c and business development flexibility, TSX Excha...stCall/ - Resverlogix Corp.,("Resverlogix") (TSX:R...llion or approximately 60% of its remaining USD$17...t and CEO of Resverlogix stated, "The,economic env... companies,around the globe. This action limits ou...

...egin after markets close at 2:00 p.m. PT ..., Oct. 15 Masimo Corporation,(Nasdaq: MASI ), th...h-Motion- and-Low-Perfusion pulse oximetry, today ...results for the period ended,September 27, 2008 af..., A conference call to review the results will be...

Other Biology Technology:Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug 2 Resverlogix Eliminates Sixty Percent of Remaining Debt 2 Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008 2

Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug Resverlogix Eliminates Sixty Percent of Remaining Debt Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008

(Date:11/22/2009)...tre, a partnership of the University of British Co...ealth Research Institute, have uncovered new infor...e following a stroke, as well as a possible way to...re recently published online in Nature Medicine .... to die even after blood flow has been restored. R...

(Date:11/20/2009)...udies about the health benefits of having a life p...vel, where amino acids known as cysteines are much...aired up with other cysteines. , Now, researcher...gues in Belgium, have discovered a new antioxidant...ch appears in the Nov. 20 issue of the journal Sc...

(Date:11/20/2009)...cientists from the Marine Biogeochemistry and Geol...Laboratory (NRL) organized and led a team of unive...ition to initiate methane hydrate exploration in t...n of sediment contribution to Arctic climate chang... Sea as a research platform, three cross-shelf tra...

Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2 Saving the single cysteine: New antioxidant system found 2 International expedition investigates climate change, alternative fuels in Arctic 2 Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1 Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2 EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1 EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2 EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3 Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 1 Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 2 Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 3 Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 4

[0] New understanding about mechanism for cell death after stroke leads to possible therapy [0] Saving the single cysteine: New antioxidant system found [0] International expedition investigates climate change, alternative fuels in Arctic

...more important for predicting biodiversity than bi...the journal Nature challenges current thinking abo...cting how climate change or human activity may aff...international group of researchers demonstrates th...tem can be accurately predicted with a simple meth...

...the genome sequence of the duck-billed platypus wa...ntists, revealing clues about how genomes were org...research was supported in part by the National Hum...National Institutes of Health (NIH). , Fans of T...platypus, native to Australia, is one of the few m...

...mmerce of ornamental stones has grown all over the...d support to the aesthetics of natural stones in b...Marble is, undoubtedly, the ornamental stone par e...ions have architectural or sculptural works which ...oric heritage. Despite this, nowadays we have a ve...

Other Biology News:Biodiversity -- it's in the water 2 Duck-billed platypus genome sequence published 2 Duck-billed platypus genome sequence published 3 Duck-billed platypus genome sequence published 4 Development of new techniques to understand marble quality and durability 2

Biodiversity -- it's in the water Duck-billed platypus genome sequence published Development of new techniques to understand marble quality and durability

PyAOP from Applied Biosystems

Nunc MicroWell Mini Trays from Invitrogen

E. coli Expression System with Gateway Technology from Invitrogen

GIBCO Leibovitz's L-15 Medium powder from Invitrogen

Biology Products:

PyAOP from Applied Biosystems Nunc MicroWell Mini Trays from Invitrogen E. coli Expression System with Gateway Technology from Invitrogen GIBCO Leibovitz's L-15 Medium powder from Invitrogen

Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prost...(a href'mailto:mwagner@debiopharm.com' ta...)